MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Accounts receivable, net$15,740K Cash and cashequivalents$62,293K Inventories$9,719K Other current assets$4,035K Intangible assets, net$2,177K Inventories, long-term$19,223K Operating leaseright-of-use assets$3,109K Other assets$646K Property and equipment,net$269K Total current assets$91,787K Total assets$117,211K Total liabilities andstockholders' equity$117,211K Total stockholders'equity$87,493K Total liabilities$29,718K Accumulated othercomprehensive income-$612K Accumulated deficit-$495,571K Additional paid-in capital$583,671K Operating leaseliabilities, long-term...$2,638K Other liabilities$935K Accrued milestones$3,200K Total currentliabilities$22,945K Common stock, 0.0001par value,...$5K Accounts payable$7,571K Operating leaseliabilities, current portion$486K Accrued liabilities$14,888K
Balance Sheet
source: myfinsight.com

Y-mAbs Therapeutics, Inc. (YMAB)

Y-mAbs Therapeutics, Inc. (YMAB)